Vascurie AB
PrivateLast Round
Seed
Feb 9, 2026
Total Funding Raised
$534,000
Company Overview
Vascurie AB is a biopharmaceutical company that develops novel antibody-based therapies for the treatment of aggressive central nervous system tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biopharmaceuticalmonoclonal antibodyneuro-oncologyglioblastomadrug discoverybrain cancer therapypreclinical developmenttumor microenvironmentbiotechCNS tumorsantibody therapeuticsCD93targeted cancer therapy
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vascurie AB Comparables
Compare Vascurie AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DynamiCure Biotechnology | 82% | |
| PharmAbcine Inc. | 70% | |
| MabTics Co., Ltd. | 67% | |
Vascurie AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 9, 2026 |
Vascurie AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Almi Invest AB | Seed |
| Uppsala University Invest | Seed |
| Kjell och Märta Beijers Stiftelse | Seed |
Vascurie AB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vascurie AB's valuation, stock price, and market status.